We compare the rates of positive reimbursement decisions in England and EU4 for orphan drugs approve...
Read moreAmylyx has set the annual price of the ALS drug to $158,000, whereas ICER have suggested the drug sh...
Read moreThis updated bill contains some similar measures to those proposed in March as well as some addition...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreThey came up with six proposals, split into three subgroups, aimed at addressing the key barriers to...
Read moreAccording to the TLV, “The prices of medicines that have been on the market between 5 and 15 years...
Read moreUnder ODAP, a protocol is drawn up “with criteria for starting, stopping and effect of a medicine....
Read moreAccording to the report, the financing of cancer drugs in Spain is “very high” with 90% of oncol...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreThe IPCEI was signed to address the need to equip Europe with a strong, innovative and export-friend...
Read more